268 related articles for article (PubMed ID: 30457049)
1. The Potential of Receptor for Advanced Glycation End Products (RAGE) as a Therapeutic Target for Lung Associated Diseases.
Khaket TP; Kang SC; Mukherjee TK
Curr Drug Targets; 2019; 20(6):679-689. PubMed ID: 30457049
[TBL] [Abstract][Full Text] [Related]
2. Glycation & the RAGE axis: targeting signal transduction through DIAPH1.
Shekhtman A; Ramasamy R; Schmidt AM
Expert Rev Proteomics; 2017 Feb; 14(2):147-156. PubMed ID: 27967251
[TBL] [Abstract][Full Text] [Related]
3. All the "RAGE" in lung disease: The receptor for advanced glycation endproducts (RAGE) is a major mediator of pulmonary inflammatory responses.
Oczypok EA; Perkins TN; Oury TD
Paediatr Respir Rev; 2017 Jun; 23():40-49. PubMed ID: 28416135
[TBL] [Abstract][Full Text] [Related]
4. The receptor for advanced glycation end-products enhances lung epithelial wound repair: An in vitro study.
Zhai R; Blondonnet R; Ebrahimi E; Belville C; Audard J; Gross C; Choltus H; Henrioux F; Constantin JM; Pereira B; Blanchon L; Sapin V; Jabaudon M
Exp Cell Res; 2020 Jun; 391(2):112030. PubMed ID: 32330509
[TBL] [Abstract][Full Text] [Related]
5. Dietary advanced glycation end-products, its pulmonary receptor, and high mobility group box 1 in aspiration lung injury.
Smit PJ; Guo WA; Davidson BA; Mullan BA; Helinski JD; Knight PR
J Surg Res; 2014 Sep; 191(1):214-23. PubMed ID: 24814199
[TBL] [Abstract][Full Text] [Related]
6. Targeting RAGE Signaling in Inflammatory Disease.
Hudson BI; Lippman ME
Annu Rev Med; 2018 Jan; 69():349-364. PubMed ID: 29106804
[TBL] [Abstract][Full Text] [Related]
7. RAGE Signaling in Skeletal Biology.
Plotkin LI; Essex AL; Davis HM
Curr Osteoporos Rep; 2019 Feb; 17(1):16-25. PubMed ID: 30685821
[TBL] [Abstract][Full Text] [Related]
8. Ousting RAGE in melanoma: A viable therapeutic target?
Syed DN; Aljohani A; Waseem D; Mukhtar H
Semin Cancer Biol; 2018 Apr; 49():20-28. PubMed ID: 29079306
[TBL] [Abstract][Full Text] [Related]
9. Receptor for Advanced Glycation End Products (RAGE) in Type 1 Diabetes Pathogenesis.
Leung SS; Forbes JM; Borg DJ
Curr Diab Rep; 2016 Oct; 16(10):100. PubMed ID: 27612847
[TBL] [Abstract][Full Text] [Related]
10. Receptor for Advanced Glycation End Products (RAGE): A Pivotal Hub in Immune Diseases.
Yue Q; Song Y; Liu Z; Zhang L; Yang L; Li J
Molecules; 2022 Aug; 27(15):. PubMed ID: 35956875
[TBL] [Abstract][Full Text] [Related]
11. Role and Mechanisms of RAGE-Ligand Complexes and RAGE-Inhibitors in Cancer Progression.
El-Far AH; Sroga G; Jaouni SKA; Mousa SA
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443845
[TBL] [Abstract][Full Text] [Related]
12. AGE-RAGE stress: a changing landscape in pathology and treatment of Alzheimer's disease.
Prasad K
Mol Cell Biochem; 2019 Sep; 459(1-2):95-112. PubMed ID: 31079281
[TBL] [Abstract][Full Text] [Related]
13. Receptor for AGE (RAGE) and its ligands-cast into leading roles in diabetes and the inflammatory response.
Yan SF; Ramasamy R; Schmidt AM
J Mol Med (Berl); 2009 Mar; 87(3):235-47. PubMed ID: 19189073
[TBL] [Abstract][Full Text] [Related]
14. The AGE-RAGE Axis and RAGE Genetics in Chronic Obstructive Pulmonary Disease.
Sharma A; Kaur S; Sarkar M; Sarin BC; Changotra H
Clin Rev Allergy Immunol; 2021 Apr; 60(2):244-258. PubMed ID: 33170477
[TBL] [Abstract][Full Text] [Related]
15. Receptor for advanced glycation end products is targeted by FBXO10 for ubiquitination and degradation.
Evankovich J; Lear T; Mckelvey A; Dunn S; Londino J; Liu Y; Chen BB; Mallampalli RK
FASEB J; 2017 Sep; 31(9):3894-3903. PubMed ID: 28515150
[TBL] [Abstract][Full Text] [Related]
16. Increased AGE-RAGE ratio in idiopathic pulmonary fibrosis.
Machahua C; Montes-Worboys A; Llatjos R; Escobar I; Dorca J; Molina-Molina M; Vicens-Zygmunt V
Respir Res; 2016 Nov; 17(1):144. PubMed ID: 27816054
[TBL] [Abstract][Full Text] [Related]
17. Receptor for advanced glycation end products: a new theraputic target for chronic obstructive pulmonary disease?
Chen L; Liu L; Wang T; Shen YC; Wen FQ
Arch Med Res; 2013 Jan; 44(1):75-6. PubMed ID: 23287523
[TBL] [Abstract][Full Text] [Related]
18. Receptor for advanced glycation end products (RAGE) signaling induces CREB-dependent chromogranin expression during neuronal differentiation.
Huttunen HJ; Kuja-Panula J; Rauvala H
J Biol Chem; 2002 Oct; 277(41):38635-46. PubMed ID: 12167613
[TBL] [Abstract][Full Text] [Related]
19. Low anticoagulant heparin targets multiple sites of inflammation, suppresses heparin-induced thrombocytopenia, and inhibits interaction of RAGE with its ligands.
Rao NV; Argyle B; Xu X; Reynolds PR; Walenga JM; Prechel M; Prestwich GD; MacArthur RB; Walters BB; Hoidal JR; Kennedy TP
Am J Physiol Cell Physiol; 2010 Jul; 299(1):C97-110. PubMed ID: 20375277
[TBL] [Abstract][Full Text] [Related]
20. Diminished Circulating Levels of Angiogenic Factors and Rage Ligands in Helminth-Diabetes Comorbidity and Reversal Following Anthelmintic Treatment.
Rajamanickam A; Munisankar S; Menon PA; Nutman TB; Babu S
J Infect Dis; 2021 Nov; 224(9):1614-1622. PubMed ID: 33822083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]